Alexion Pharmaceuticals (ALXN) PT Raised to $155 at SunTrust

July 31, 2020 7:10 AM

SunTrust analyst Robyn S. Karnauskas raised the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $155.00 (from $135.00) while maintaining a Buy rating.

No results found